The Corona Drug Survey is conducted by the Psychotropic Substances Group of Charité – Universitätsmedizin Berlin. The aim of the study is to determine how the consumption of psychoactive substances has changed as a result of the COVID-19 pandemic (“corona crisis”). In the Corona Drug Survey (CDS), we investigate how the current situation affects the subjective experience and use of psychoactive substances. We also want to find out whether there are differences between substances.
PARTICIPATION IS ANONYMOUS
Participation in the survey is completely anonymous and no IP address is stored. It is therefore not possible for us to track who filled out the questionnaire.
is a psychiatrist, psychotherapist and head of the Psychotropic Substances Research Group at the Psychiatric University Hospital Charité at St. Hedwig Hospital in Berlin. He is head of the Outpatient Clinic and Day Clinic for Dual Diagnosis and the Outpatient Clinic for Psychoactive Substances, where people who have experienced mental disorders or problems integrating difficult experiences after taking psychedelics or other substances are treated.
PD Dr. Inge Maria Mick
is a psychiatrist and psychotherapist at the Psychiatric University Hospital Charité at St. Hedwig Hospital in Berlin. She is head of the outpatient department for addictive disorders and leads a general psychiatric ward.
PD Dr. Christiane Montag
is a specialist in psychiatry and psychotherapy / psychoanalysis at the Psychiatric University Hospital Charité at St. Hedwig Hospital in Berlin. She is head of the research area Psychotic Diseases and is particularly interested in the effectiveness of psychotherapy, but also in empathy and emotionality in people with psychoses. Her clinical field of activity is general psychiatry and a model project for need-based treatment.
Dr. Ricarda Evens
is a psychologist, psychotherapist and member of the Psychotropic Substances Research Group at the Department of Psychiatry and Psychotherapy at the Psychiatric University Hospital Charité at St. Hedwig Hospital. Her research focuses on potential benefits of substance-assisted psychotherapy.
In cooperation with Felix Betzler, M.D. Research Group Recreational Drugs Charité Campus Mitte